Fundraising Fox

Iqbal Mufti

Investor

Operating Partner at SR One Capital Management

London

About

Iqbal Mufti is an Operating Partner at SR One's London office, working on company creation, later-stage investments, and portfolio companies' industry engagement and partnering strategy. He previously worked at Hoffmann-La Roche, where he co-led the rare blood disorders portfolio strategy team and served as global Lifecycle Leader for Hemlibra (emicizumab). His background covers pharmaceutical product and portfolio strategy, late-stage development, global commercialization, business development, and M&A. He holds a BSc in Biotechnology from University College London and an MBA from Duke University's Fuqua School of Business.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. SR One Capital ManagementVenture Partnercurrent2022 — presentLondon, England, United Kingdom / Basel, Switzerland
  2. Windward BioBoard Membercurrent2025 — presentBasel, Basel, Switzerland
  3. Econic BiosciencesBoard Membercurrent2025 — presentLondon, England, United Kingdom
  4. Antag TherapeuticsBoard Observercurrent2024 — presentCopenhagen, Denmark
  5. CORXEL PharmaceuticalsBoard Observercurrent2026 — presentNew York, New York, United States
  6. Vibrant Biomedicines, Inc.Board Member2024 — 2025Boston, Massachusetts, United States
  7. RocheCo-Lead Disease Area Strategy Team - Rare Blood Disorders Franchise2020 — 2022Basel, Switzerland
  8. RocheLifecycle Leader - Haemophilia (Hemlibra)2019 — 2022Basel, Basel, Switzerland
  9. RocheIntegrated Strategy Leader - Haemophilia (Hemlibra)2018 — 2019Basel, Basel, Switzerland
  10. RocheCommercial Director (Global Commercial Head - Hemlibra)2018Basel, Basel, Switzerland
  11. RocheInternational Business Leader - Haemophilia2016 — 2018Basel, Basel, Switzerland
  12. RocheBusiness Unit Head - Sales & Marketing2015 — 2016Egypt
  13. Roche / GenentechGlobal Head Strategic Partnering - Ad Interim2014South San Francisco
  14. Roche / GenentechGlobal Business Development Director - Strategic Partnering2011 — 2014South San Francisco
  15. Hoffmann-La RocheGlobal Business Development Director, Strategic Partnering2010 — 2011New Jersey
  16. Hoffmann-La RocheGlobal Business Development Manager - Commercial Assessment2008 — 2010
  17. Roche PharmaceuticalsDirector - Commercial Operations2004 — 2007

Skills & more

Strategic Partnerships21Biotechnology32Lifesciences6Oncology13Drug Development7Biopharmaceuticals23Clinical Development6Pharmaceutical Industry30

From Iqbal's professional profile.

Colleagues at SR One Capital Management

Frequently asked questions

Who is Iqbal Mufti?
Iqbal Mufti is an Operating Partner at SR One's London office, working on company creation, later-stage investments, and portfolio companies' industry engagement and partnering strategy. He previously worked at Hoffmann-La Roche, where he co-led the rare blood disorders portfolio strategy team and served as global Lifecycle Leader for Hemlibra (emicizumab). His background covers pharmaceutical product and portfolio strategy, late-stage development, global commercialization, business development, and M&A. He holds a BSc in Biotechnology from University College London and an MBA from Duke University's Fuqua School of Business.
Where does Iqbal Mufti work?
Iqbal Mufti is Operating Partner at SR One Capital Management.
What does Iqbal Mufti invest in?
Iqbal Mufti invests in Biotech.
Where did Iqbal Mufti go to school?
Iqbal Mufti studied at Duke University - The Fuqua School of Business (MBA); UCL (BSc Hons, Biotechnology).

Same school

Shared employers